search button

High expression of SDF‑1 and VEGF is associated with poor prognosis in patients with synovial sarcomas

  • Authors:
    • Qi Feng
    • Peng Guo
    • Jin Wang
    • Xiaoyu Zhang
    • Hui‑Chai Yang
    • Jian‑Gang Feng

  • View Affiliations

  • Published online on: January 2, 2018     https://doi.org/10.3892/etm.2018.5684
  • Pages: 2597-2603
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Stromal cell‑derived factor‑1 (SDF‑1) predicts poor clinical outcomes of certain types of cancer. Furthermore, vascular endothelial growth factor (VEGF) promotes the growth and metastasis of solid tumors. The aim of the present study was to examine the expression of SDF‑1 and VEGF in patients with synovial sarcoma and to determine their expression is correlated with unfavorable outcomes. Levels of SDF‑1 and VEGF proteins were evaluated in 54 patients with synovial sarcoma using immunohistochemical and immunofluorescence staining. Potential associations between the expression of SDF‑1 and VEGF and various clinical parameters were analyzed using Pearson's χ2 test and the Spearman‑rho test. Additionally, univariate and multivariate Cox regression analyses were used to identify potential prognostic factors, and the Kaplan‑Meier method was used to analyze the overall survival rates of patients. Low SDF‑1 and VEGF expression was detected in 20.4% (11/54) and 22.2% (12/54) of patients with synovial sarcoma; moderate expression was detected in 35.2% (19/54) and 37.0% (20/54) of patients and high expression was detected in 44.4% (24 of 54) and 40.7% (22 of 54) of patients, respectively. Levels of SDF‑1 and VEGF proteins were significantly associated with histological grade (P<0.05), metastasis (P<0.05) and American Joint Committee on Cancer staging (P<0.05). In addition, levels of SDF‑1 and VEGF expression were positively correlated with each other (P<0.001). Univariate analysis also indicated that VEGF expression was associated with shorter overall survival rates in (P<0.05), whereas multivariate analysis demonstrated that SDF‑1 expression was associated with shorter patient survival rates (P<0.05). Finally, both SDF‑1 and VEGF expression were associated with various characteristics of synovial sarcoma. Therefore, SDF‑1 expression may be a potential independent prognostic indicator in patients with synovial sarcomas.
View Figures
View References

Related Articles

Journal Cover

March-2018
Volume 15 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.7
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Feng Q, Guo P, Wang J, Zhang X, Yang HC and Feng JG: High expression of SDF‑1 and VEGF is associated with poor prognosis in patients with synovial sarcomas. Exp Ther Med 15: 2597-2603, 2018
APA
Feng, Q., Guo, P., Wang, J., Zhang, X., Yang, H., & Feng, J. (2018). High expression of SDF‑1 and VEGF is associated with poor prognosis in patients with synovial sarcomas. Experimental and Therapeutic Medicine, 15, 2597-2603. https://doi.org/10.3892/etm.2018.5684
MLA
Feng, Q., Guo, P., Wang, J., Zhang, X., Yang, H., Feng, J."High expression of SDF‑1 and VEGF is associated with poor prognosis in patients with synovial sarcomas". Experimental and Therapeutic Medicine 15.3 (2018): 2597-2603.
Chicago
Feng, Q., Guo, P., Wang, J., Zhang, X., Yang, H., Feng, J."High expression of SDF‑1 and VEGF is associated with poor prognosis in patients with synovial sarcomas". Experimental and Therapeutic Medicine 15, no. 3 (2018): 2597-2603. https://doi.org/10.3892/etm.2018.5684